Skip to main navigation

Home
News & Presentations
Governance
Financials
Stock Information
Resources

News Releases

News Releases

Year

Jun 09, 2021

Arcutis Announces Appointment of Sue-Jean Lin to Board of Directors

Jun 01, 2021

Rajvir Madan Joins Arcutis as Chief Digital and Information Officer

May 06, 2021

Arcutis Biotherapeutics Showcases Pivotal DERMIS-1 and -2 Phase 3 Trial Data for Topical Roflumilast Cream (ARQ-151) in Plaque Psoriasis at EADV Spring Symposium 2021

May 04, 2021

Arcutis Announces First Quarter 2021 Financial Results and Provides Business Update

May 03, 2021

Arcutis to Present New Roflumilast Cream Phase 3 Data at The European Academy of Dermatology and Venereology (EADV) Spring Symposium

Apr 28, 2021

Arcutis to Present at the 2021 Truist Securities Life Sciences Summit

Apr 23, 2021

Arcutis Biotherapeutics Showcases New Roflumilast Data in Psoriasis and Seborrheic Dermatitis at American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX) 2021

Apr 19, 2021

Arcutis Biotherapeutics to Present New Roflumilast Data at The American Academy of Dermatology (AAD) Virtual Meeting Experience (VMX)

Apr 12, 2021

Arcutis Initiates Phase 3 Clinical Trial of Topical Roflumilast Cream (ARQ-151) as a Potential Treatment for Atopic Dermatitis in Pediatric Patients Between the Ages of Two and Five Years

Mar 26, 2021

Arcutis Announces Updates to its Executive Team

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 22

Print Page

RSS Feeds

Email Alerts

Search

information@arcutis.com

linkedin

Who We Are
Our Focus
Pipeline
Clinical Trials
Investors
Contact
News / Press
Legal Disclaimer

© 2021 Arcutis Biotherapeutics